Nestlé divests its Palforzia business
This agreement follows Nestlé's announcement last year that it would conduct a strategic review of Palforzia
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
05 Sep 23
This agreement follows Nestlé's announcement last year that it would conduct a strategic review of Palforzia
31 Jul 23
The acquisition is aimed at bolstering Sanofi's Consumer Healthcare (CHC) division, particularly in the Vitamin, Mineral, and Supplements…
26 Jul 23
Solar Biotech Canada will transform consumer goods to ensure a sustainable future
04 Jul 23
Through its B2C division, i-Health, dsm-firmenich plans to increase access to Lactéol, which is the over-the-counter postbiotic supplement…
04 Jul 23
United Malt is a commercial maltster that makes bulk malt for brewers, craft brewers, distillers, and food companies…
15 Jul 22
Upon completion of the proposed acquisition, which includes Endura brand and all its associated trademarks, CHL intends to…
03 Mar 22
The acquisition is expected to expand Aceto’s nutraceuticals capabilities and complements its footprint in the expanding life sciences…
29 Jul 21
The sale involves the transfer of Sanofi India’s 16 nutraceutical brands in the portfolio to Universal Nutriscience
01 Sep 20
Aimmune’s FDA approved Palforzia therapy is expected to expand Nestlé Health Science’s portfolio to reduce the severity of…
11 Jun 20
Vital Proteins will become a part of the Nestlé Health Science portfolio, and will benefit from a variety…